Compare HST & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HST | PEN |
|---|---|---|
| Founded | 1927 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 10.9B |
| IPO Year | N/A | 2015 |
| Metric | HST | PEN |
|---|---|---|
| Price | $18.36 | $312.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 16 |
| Target Price | $18.65 | ★ $311.25 |
| AVG Volume (30 Days) | ★ 7.0M | 487.3K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | ★ 4.90% | N/A |
| EPS Growth | 3.27 | ★ 367.34 |
| EPS | 1.06 | ★ 4.14 |
| Revenue | ★ $5,950,000,000.00 | $1,333,798,000.00 |
| Revenue This Year | $6.31 | $16.77 |
| Revenue Next Year | $1.80 | $14.12 |
| P/E Ratio | ★ $17.35 | $75.25 |
| Revenue Growth | 6.44 | ★ 14.61 |
| 52 Week Low | $12.22 | $221.26 |
| 52 Week High | $19.03 | $315.01 |
| Indicator | HST | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 64.76 | 67.99 |
| Support Level | $17.04 | $286.75 |
| Resistance Level | $17.69 | $303.00 |
| Average True Range (ATR) | 0.37 | 8.69 |
| MACD | 0.06 | 0.81 |
| Stochastic Oscillator | 89.42 | 92.00 |
Host Hotels & Resorts owns 80 predominantly urban and resort upper-upscale and luxury hotel properties representing nearly 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.